After participating in this webinar, the learner will be able to:

1. Describe the evolving role of machine perfusion in the evaluation and preservation of cardiothoracic organs.
2. Describe the evolving role of machine perfusion in the evaluation and preservation of abdominal organs.
3. Describe the evolving role of the Organ Procurement Organization (OPO) in the coordination of the logistics involved in the use of machine perfusion.
4. Understand at a high level who pumps, who pays, and who benefits.

After participating in this webinar, the learner will be able to:

• Be knowledgeable of background data regarding hepatitis C (HCV) in solid organ transplant
  
• Describe relevant considerations in the assessment of potential living donors with active or prior HCV infection which may impact donor and recipient outcomes
  
• Appreciate a framework for the screening and evaluation of such donors
  
• Describe waitlist management and ethical considerations

After participating in this webinar, the learner will be able to:

• Explain the evolution of pharmacy and advanced practice providers in solid organ transplant.
  
• Share current inpatient multidisciplinary practice models.
  
• Describe the various roles of pharmacists and advanced practice providers in the outpatient setting.
  
• Discuss future opportunities for transplant pharmacists and advanced practice providers.

After participating in this webinar, the learner will be able to:

1. Describe the core concepts underlying the disease of addiction.
2. Understand implications of prescription opioid use, benzodiazepine use, and cannabis use disorder before and after transplant on recipient outcomes, at the population-level.
3. Identify the implications of prescription opioid use on living donor outcomes, at the population level.
4. Understand the risks of relapse to substance use disorders and factors that may predict relapse risk.
5. Discuss current controversies that relate to substance use and transplantation, including marijuana use and transplantation for acute alcoholic hepatitis.

After participating in this webinar, the learner will be able to:

1. Understand the risk factors for and impact of multidrug-resistant organisms on transplant recipients
2. Review novel therapeutics for multidrug-resistant organism infections in transplant recipients
3. Understand antimicrobial stewardship concepts and their importance in solid organ transplantation
4. Describe the current state of antimicrobial stewardship in solid organ transplantation and identify implementation opportunities

After participating in this webinar, the learner will be able to:

• Discuss the importance of preventing physician burnout and suicide.
• Examine lessons learned from the front line of physician burnout and suicide.
• Discuss next steps in protecting physician well-being to prevent negative mental health outcomes

After participating in this webinar, the learner will be able to:

• Review racial inequities in access to pre-emptive waitlisting and kidney transplantation that are enabled by flawed features of the US allocation system.
• Review results of survey on opinions of transplant clinicians on use of race in estimating GFR (conducted by AST's Kidney Pancreas Community of Practice Public Policy Work Group).
• Review final recommendations from the American Society of Nephrology (ASN) & National Kidney Foundation (NKF) Task Force to understand: a) Relevance in today’s practice, and b) Trials and tribulations

After participating in this webinar, the learner will be able to:

1. Understand factors and methods to identify an acceptable donor.
2. Understand impact of using or not using, acceptable donors on post-transplant outcomes.
3. Understand practical methods of matching acceptable donors to appropriate lung transplant recipients.

After participating in this webinar, the learner will be able to:

• Understand incorporation of sex as a biological variable into human clinical research.
• Identify mechanisms mediating how hormones and sex chromosome complement differentially affect immune responses and outcomes of infection and vaccination.
• Describe what clinical differences have been identified in transplant-related infection and vaccination.
• Explain limitations and gaps in knowledge to be addressed in future research.

After participating in this webinar, the learner will be able to:

• Understand our process of eIND approval, background data.
• Understand the postoperative course, xenograft function.
• Understand what we learned from our experience